EDadmin@hermes.cam.ac.uk
01223 763384
Members Area
Members Area
EDadmin@hermes.cam.ac.uk
01223 763384
Members Area
Members Area
Published: 19th September, 2018
This year's Cambridge Festival of Ideas shines the spotlight on health; talks about diet are featured and even a seminar on whether marriage is better for our health. The Early Detection programme contributes with a talk on the overdiagnosis of cancer.
Cancer screening comes under scrutiny during the CRUK Cambridge Centre Early Detection Programme event Cancer overdiagnosis: what is it? on 26th October. Speakers include Dr Stephen John, Hatton Lecturer in the Philosophy of Public Health and Dr Maryon McDonald, Fellow in Social Anthropology at Robinson College, Cambridge, who discuss some of the issues around cancer screening and diagnosis.
Published: 18th September, 2018
Congratulations to Dr Daniel Muñoz-Espín, Early Detection Programme Group Leader, and Dr Jim Korkola, Professor of Biomedical Engineering at OHSU, who have been awarded the CRUK-OHSU Project Award for their project entitled: Dissecting the role of the senescent secretome in tumorigenesis.
Published: 10th September, 2018
The BEST3 cytosponge clinical trial has recruited its thousandth patient. Rebecca Fitzgerald explains more about the device in a live interview on BBC Look East.
Published: 04th September, 2018
Cancer Research UK have published their Annual Review for 2017/18 with a major focus on the Early Detection of Cancer. Pages 30-39 feature the chapter "Detecting and Diagnosing Cancer" which includes an article on Owlstone Medical and the PAN Cancer Trial that the company is running with the CRUK Cambridge Centre Early Detection Programme to detect cancer in breath samples.
The document also includes an interview with Sir Harpal Kumar, who stepped down as Chief Executive after more than 15 years with the charity. In his future vision he comments: “I hope it will include something in the area of early detection. We’re getting towards a breakthrough that’ll allow us to detect cancers at an early stage – including some of the most aggressive, dangerous ones – and that’s going to have a huge impact on survival.”
Please click here to open the report.
Published: 29th August, 2018
From September 2018 Cancer Research UK is removing the post-PhD time restrictions on applications for response-mode fellowships to ensure greater flexibility and equality.
Published: 22nd August, 2018
Trial aims to identify breath biomarkers to improve the early detection and diagnosis of different cancer types.
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, will run the PAN Cancer trial for Early Detection of Cancer in Breath. The large scale clinical study will evaluate the use of Owlstone Medical’s Breath Biopsy® platform for the early detection of multiple cancer types.
Published: 01st August, 2018
New study reveals that it is possible to identify people at high risk of developing Acute Myeloid Leukaemia (AML) years before they became ill.
Published: 30th July, 2018
Successful application to Rosetrees Trust Interdisciplinary Prize 2018 for non-invasive diagnostic test for renal cell cancers at point of care.
Published: 16th July, 2018
The International Cell Senescence Association (ICSA) conference 2018 took place from July 8th-11th in Montreal, Canada and was attended by members of the Munoz-Espin lab. Estela Gonzalez-Gualda, PhD student in the lab, was awarded a poster prize at the conference. Many congratulations Estela.
Published: 03rd July, 2018
Mr Vincent Gnanapragasam and Professor Andrew Flewitt featured on the BBC Look East Evening News of 2 July 2018. They have both been working on new devices to improve accuracy in prostate cancer detection. The coverage shows both tools, the CamProbe and the FBAR which should be safer and more accurate than the current PSA test.